OBJECTIVE: To determine the relative amount of virus produced by activated and resting CD4+ T cells. DESIGN: The total quantity of virus produced by an activated cell relative to a resting cell in vivo was estimated from 'snap-shots' of virus production by infected cells at one time point. METHODS: Bayesian statistical methods were used to determine a credible interval for the desired ratio. RESULTS: The posterior mean of the ratio of virus produced by a typical activated cell to a typical resting cell is 0.82 to 4.28, depending on the half-lives of the resting infected cells. Simian immunodeficiency virus-infected resting cells could accordingly be responsible for 70 to 93% of peak virus production in the acute stage of infection. CONCLUSIONS: Whereas in 'snap-shots' the infected resting cells apparently produce much less virus than infected activated CD4+ T cells, the coincidence of peak SIV production with predominant infection of resting cells along with longer half-lives for productively infected resting cells point to a major contribution to virus production in early infection.
OBJECTIVE: To determine the relative amount of virus produced by activated and resting CD4+ T cells. DESIGN: The total quantity of virus produced by an activated cell relative to a resting cell in vivo was estimated from 'snap-shots' of virus production by infected cells at one time point. METHODS: Bayesian statistical methods were used to determine a credible interval for the desired ratio. RESULTS: The posterior mean of the ratio of virus produced by a typical activated cell to a typical resting cell is 0.82 to 4.28, depending on the half-lives of the resting infected cells. Simian immunodeficiency virus-infected resting cells could accordingly be responsible for 70 to 93% of peak virus production in the acute stage of infection. CONCLUSIONS: Whereas in 'snap-shots' the infected resting cells apparently produce much less virus than infected activated CD4+ T cells, the coincidence of peak SIV production with predominant infection of resting cells along with longer half-lives for productively infected resting cells point to a major contribution to virus production in early infection.
Authors: Yoshiaki Nishimura; Reza Sadjadpour; Joseph J Mattapallil; Tatsuhiko Igarashi; Wendy Lee; Alicia Buckler-White; Mario Roederer; Tae-Wook Chun; Malcolm A Martin Journal: Proc Natl Acad Sci U S A Date: 2009-04-27 Impact factor: 11.205
Authors: Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy Journal: J Virol Date: 2013-09-18 Impact factor: 5.103
Authors: Courtney V Fletcher; Kathryn Staskus; Stephen W Wietgrefe; Meghan Rothenberger; Cavan Reilly; Jeffrey G Chipman; Greg J Beilman; Alexander Khoruts; Ann Thorkelson; Thomas E Schmidt; Jodi Anderson; Katherine Perkey; Mario Stevenson; Alan S Perelson; Daniel C Douek; Ashley T Haase; Timothy W Schacker Journal: Proc Natl Acad Sci U S A Date: 2014-01-27 Impact factor: 11.205
Authors: Bhawna Poonia; Maria S Salvato; Hideo Yagita; Toshihiro Maeda; Ko Okumura; C David Pauza Journal: Blood Date: 2009-06-04 Impact factor: 22.113
Authors: Janka Petravic; Paula Ellenberg; Ming-Liang Chan; Geza Paukovics; Redmond P Smyth; Johnson Mak; Miles P Davenport Journal: J Virol Date: 2013-11-06 Impact factor: 5.103